Perrigo (PRGO) Cash from Investing Activities Growth (3y) (2016 - 2026)
Perrigo (PRGO) Cash from Investing Activities Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.87 Bn | 42.91 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.00 Bn | 39.35 Bn | 2.15 Bn | -53.63% |
| 3 | Zoetis | 31.59 Bn | 29.92 Bn | 1.05 Bn | -55.36% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 34.35% |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | 33.61% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 15.92% |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | -2.45% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -36.76% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Perrigo | 1.93 Bn | 1.54 Bn | 313.90 Mn | 333.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 333.40% |
| Mar 28, 2026 | 14.15% |
| Dec 31, 2025 | 1.96% |
| Sep 27, 2025 | -0.79% |
| Jun 28, 2025 | 87.56% |
| Mar 29, 2025 | -34.07% |
| Dec 31, 2024 | 3.97% |
| Sep 28, 2024 | -47.30% |
| Jun 29, 2024 | -49.81% |
| Mar 30, 2024 | 40.93% |
| Dec 31, 2023 | 43.66% |
| Sep 30, 2023 | 7.35% |
| Jul 1, 2023 | -27.71% |
| Apr 1, 2023 | 36.01% |
| Dec 31, 2022 | 37.46% |
| Oct 1, 2022 | 68.23% |
| Jul 2, 2022 | -207.21% |
| Apr 2, 2022 | -35.17% |
| Dec 31, 2021 | 3.13% |
| Oct 2, 2021 | 211.49% |